Aliases & Classifications for Cerebral Aneurysms

Aliases & Descriptions for Cerebral Aneurysms:

Name: Cerebral Aneurysms 51 29
Cerebral Aneurysm 52 69
Cerebral Arterial Aneurysm 69

Summaries for Cerebral Aneurysms

NINDS : 51 A cerebral aneurysm is a weak or thin spot on a blood vessel in the brain that balloons out and fills with blood.  An aneurysm can press on a nerve or surrounding tissue, and also leak or burst, which lets blood spill into surrounding tissues (called a hemorrhage). Cerebral aneurysms can occur at any age, although they are more common in adults than in children and are slightly more common in women than in men.  The signs and symptoms of an unruptured cerebral aneurysm will partly depend on its size and rate of growth. For example, a small, unchanging aneurysm will generally produce no symptoms, whereas a larger aneurysm that is steadily growing may produce symptoms such as headache, numbness, loss of feeling in the face or problems with the eyes. Immediately after an aneurysm ruptures, an individual may experience such symptoms as a sudden and unusually severe headache, nausea, vision impairment, vomiting, and loss of consciousness.

MalaCards based summary : Cerebral Aneurysms, also known as cerebral aneurysm, is related to aneurysm and intracranial berry aneurysm. An important gene associated with Cerebral Aneurysms is ELN (Elastin), and among its related pathways/superpathways are Degradation of the extracellular matrix and C-MYB transcription factor network. The drugs Aspirin and Sevoflurane have been mentioned in the context of this disorder. Affiliated tissues include brain, eye and endothelial.

Related Diseases for Cerebral Aneurysms

Diseases related to Cerebral Aneurysms via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 123)
id Related Disease Score Top Affiliating Genes
1 aneurysm 11.6
2 intracranial berry aneurysm 11.4
3 intracranial aneurysm 11.4
4 cerebritis 10.9
5 berry aneurysm, cirrhosis, pulmonary emphysema, and cerebral calcification 10.8
6 loeys-dietz syndrome 4 10.8
7 uveitis 10.1 CCL2 MPO
8 benign focal seizures of adolescence 10.1 ELANE ELN
9 optic nerve glioma 10.1 ELANE ELN
10 tetanus 10.1 ELANE ELN
11 immune-complex glomerulonephritis 10.1 CCL2 MPO
12 bardet-biedl syndrome 8 10.1 ELANE ELN
13 benign secondary hypertension 10.1 CCL2 MPO
14 strawberry gallbladder 10.1 CCL2 MPO
15 brucella suis brucellosis 10.1 ELANE MPO
16 subacute glomerulonephritis 10.1 ELANE MPO
17 dysentery 10.1 ELANE MPO
18 omsk hemorrhagic fever 10.1 ELANE MPO
19 pancreatic serous cystadenoma 10.1 ELANE MPO
20 breast apocrine carcinoma in situ 10.1 CCL2 MPO
21 alcoholic hepatitis 10.1 ELANE ELN
22 malignant testicular leydig cell tumor 10.1 ELANE MPO
23 retinitis pigmentosa 51 10.1 ELANE ELN
24 infancy electroclinical syndrome 10.1 CCL2 ELANE
25 renal oncocytoma 10.0 ELANE ELN
26 malignant neoplasm of acoustic nerve 10.0 CCL2 ELANE
27 familial cerebral saccular aneurysm 10.0
28 fasciitis 10.0 ELANE MPO
29 focal dystonia 10.0 CCL2 CST3
30 hyperuricemia, pulmonary hypertension, renal failure, and alkalosis 10.0 CCL2 ELANE
31 bare lymphocyte syndrome, type i 10.0 CCL2 ELANE MPO
32 familial renal papillary carcinoma 10.0 ELANE MPO
33 acute chest syndrome 10.0 CCL2 ELANE MPO
34 eating disorder 10.0 CCL2 ELANE MPO
35 heart valve disease 9.9 CCL2 ELANE MPO
36 rectum squamous cell carcinoma 9.9 CCL2 ELANE MPO
37 major depressive disorder and accelerated response to antidepressant drug treatment 9.9 ELANE ELN MPO
38 arteriovenous malformation 9.9
39 intratubular embryonal carcinoma 9.9 CCL2 CTSB ELANE
40 hyperlysinemia 9.9 ELANE ELN MPO
41 lacrimal system cancer 9.9 CTSB ELANE MPO
42 pericarditis 9.8 CCL2 CST3 ELN
43 thrombosis 9.8
44 headache 9.8
45 hydrocephalus 9.8
46 subcorneal pustular dermatosis 9.8 CCL2 ELANE ELN MPO
47 calcinosis 9.8 CCL2 CST3
48 takayasu arteritis 9.8
49 endotheliitis 9.8
50 fibromuscular dysplasia 9.7

Graphical network of the top 20 diseases related to Cerebral Aneurysms:



Diseases related to Cerebral Aneurysms

Symptoms & Phenotypes for Cerebral Aneurysms

Drugs & Therapeutics for Cerebral Aneurysms

Drugs for Cerebral Aneurysms (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 249)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Aspirin Approved, Vet_approved Phase 4,Phase 3,Phase 1 50-78-2 2244
2
Sevoflurane Approved, Vet_approved Phase 4,Phase 3,Phase 2 28523-86-6 5206
3
Acetazolamide Approved, Vet_approved Phase 4,Phase 2 59-66-5 1986
4
Propofol Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2 2078-54-8 4943
5
Morphine Approved, Investigational Phase 4 57-27-2 5288826
6
Amlodipine Approved Phase 4 88150-42-9 2162
7
Olmesartan Approved, Investigational Phase 4,Phase 3 144689-24-7, 144689-63-4 158781 130881
8
Ticlopidine Approved Phase 4,Phase 3 55142-85-3 5472
9
Dexmedetomidine Approved, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2 76631-46-4, 113775-47-6 68602 5311068 56032
10
Isoflurane Approved, Vet_approved Phase 4 26675-46-7 3763
11
Benzocaine Approved Phase 4,Phase 1,Phase 2,Early Phase 1 1994-09-7, 94-09-7 2337
12
Sufentanil Approved, Investigational Phase 4 56030-54-7 41693
13
Desflurane Approved Phase 4 57041-67-5 42113
14
Coal tar Approved Phase 4 8007-45-2
15 Piracetam Approved Phase 4 7491-74-9
16
Clopidogrel Approved, Nutraceutical Phase 4,Phase 3 120202-66-6, 113665-84-2 60606
17 tannic acid Approved, Nutraceutical Phase 4,Phase 1,Phase 2,Early Phase 1
18 Analgesics Phase 4,Phase 3,Phase 2,Phase 1
19 calcium channel blockers Phase 4,Phase 3,Phase 2,Phase 1
20 diuretics Phase 4,Phase 1,Phase 2
21 Natriuretic Agents Phase 4,Phase 3,Phase 1,Phase 2
22 Neuroprotective Agents Phase 4,Phase 2,Phase 3,Phase 1
23 Neurotransmitter Agents Phase 4,Phase 3,Phase 2,Phase 1
24 Nootropic Agents Phase 4,Phase 2,Phase 3
25 Anesthetics Phase 4,Phase 3,Phase 2,Phase 1
26 Anesthetics, General Phase 4,Phase 3,Phase 2
27 Anesthetics, Inhalation Phase 4,Phase 3,Phase 2
28 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2,Phase 1
29 Platelet Aggregation Inhibitors Phase 4,Phase 3,Phase 2,Phase 1
30 Fibrinolytic Agents Phase 4,Phase 3,Phase 2,Phase 1
31 Anticonvulsants Phase 4,Phase 2
32 Protective Agents Phase 4,Phase 2,Phase 3
33 Antihypertensive Agents Phase 4,Phase 3,Phase 2,Phase 1
34 Carbonic Anhydrase Inhibitors Phase 4,Phase 2
35 Calcium, Dietary Phase 4,Phase 3,Phase 2,Phase 1
36 Central Nervous System Depressants Phase 4,Phase 3,Phase 2,Phase 1
37
Angiotensin II Phase 4,Phase 3 68521-88-0, 11128-99-7 65143 172198
38
Olmesartan medoxomil Phase 4,Phase 3 144689-63-4 130881
39 Epoetin alfa Phase 4,Phase 2 113427-24-0
40 Adjuvants, Anesthesia Phase 4,Phase 2
41 Adrenergic Agents Phase 4,Phase 3,Phase 1,Phase 2
42 Narcotics Phase 4
43 Adrenergic Agonists Phase 4,Phase 3,Phase 1,Phase 2
44 Adrenergic alpha-2 Receptor Agonists Phase 4,Phase 3,Phase 1,Phase 2
45 Adrenergic alpha-Agonists Phase 4,Phase 3,Phase 1,Phase 2
46 Cyclooxygenase Inhibitors Phase 4,Phase 3,Phase 1
47 Hematinics Phase 4,Phase 2,Phase 1
48 Cytochrome P-450 Enzyme Inhibitors Phase 4,Phase 3
49 Analgesics, Non-Narcotic Phase 4,Phase 3,Phase 1,Phase 2
50 Analgesics, Opioid Phase 4

Interventional clinical trials:

(show top 50) (show all 304)
id Name Status NCT ID Phase
1 Treatment of Cranial Internal Carotid Artery Aneurysm With Willis Covered Stent and Coil Embolization Unknown status NCT01029938 Phase 4
2 HYdrogel Coil Versus Bare Platinum Coil in Recanalization Imaging Data Study Unknown status NCT01516658 Phase 4
3 Delayed Vasospasm After Aneurysm With the Standardization Treatment of Traditional Chinese Medicine Unknown status NCT01840761 Phase 4
4 Effectiveness of Acetazolamide in Reducing Paralysis of the Leg in Patients Undergoing Aortic Aneurysm Surgery Surgery Unknown status NCT01889498 Phase 4
5 TRAIL: Treatment of Intracranial Aneurysms With LVIS® System Completed NCT02921711 Phase 4
6 Role of Propofol Postconditioning on Oxidative Stress and Cognitive Function Completed NCT02691416 Phase 4
7 The Registry to Study Safety and Performance of the CORDIS Vascular Reconstruction Device and Delivery System Completed NCT00486226 Phase 4
8 PRET: Patients Prone to Recurrence After Endovascular Treatment Completed NCT00626912 Phase 4
9 Aneurysm Wall Histology Registry Completed NCT01444664 Phase 4
10 MAPS Trial: Matrix And Platinum Science Completed NCT00396981 Phase 4
11 A Better Choice for Patients Undergoing Endovascular Coil Embolization Completed NCT01722409 Phase 4
12 Comparison of Neuroprotection by Propofol and Desflurane for POCD Following Subarachnoid Hemorrhage Surgery Completed NCT02987218 Phase 4
13 The Pharmacokinetics of Opioids and Sedative/Hypnotics During Selective Cerebral Perfusion Completed NCT00494598 Phase 4
14 Effects of a Surgery-induced Peripheral Inflammatory Response on the Blood Brain Barrier Completed NCT00878371 Phase 4
15 Researching AXIUM Coiling Experience and Recanalization (RACER) Completed NCT00703794 Phase 4
16 OlmeSartan and Calcium Antagonists Randomized (OSCAR) Study Completed NCT00134160 Phase 4
17 TARGET Intracranial Aneurysm Coiling Registry Recruiting NCT01748903 Phase 4
18 Flow Diversion in Intracranial Aneurysm Treatment Recruiting NCT01349582 Phase 4
19 Stenting in the Treatment of Aneurysm Trial Recruiting NCT01340612 Phase 4
20 Assessment of the Embolization of Neurovascular Lesions Using the Penumbra Smart Coil Recruiting NCT02729740 Phase 4
21 Seizure Prophylaxis in Aneurysm Repair Recruiting NCT01801072 Phase 4
22 LARGE Aneurysm Randomized Trial: Flow Diversion Versus Traditional Endovascular Coiling Therapy Recruiting NCT01762137 Phase 4
23 Yellow 560 Microscope for Intraoperative Visualization of Fluorescein Stained Intracranial Lesions Recruiting NCT02478346 Phase 4
24 Study of the Penumbra Coil 400 System to Treat Aneurysm Active, not recruiting NCT01465841 Phase 4
25 Study of Antiplatelet Therapy for Intracranial Aneurysm Stent-assisted Coiling Not yet recruiting NCT02224131 Phase 4
26 HydroCoil Cerebral Aneurysm Treatment Trial Terminated NCT01195129 Phase 4
27 Seizure Prophylaxis in Aneurysm Repair Terminated NCT01974700 Phase 4
28 Treating Patients With Aneurysmal SubArachnoid Hemorrhage (SAH) With Epoetin Alfa Terminated NCT00626574 Phase 4
29 Yellow 560 Microscope for Intraoperative Visualization of Fluorescein Stained Intracranial Lesions Terminated NCT02028325 Phase 4
30 Hydrogel Balloon Assisted Intracranial Aneurysm Coiling Registry Withdrawn NCT02037932 Phase 4
31 Randomized, Double-blind, Placebo-controlled Trial to Investigate Safety and Efficacy of Cerebrolysin™ in Patients With Aneurysmal Subarachnoid Hemorrhage Unknown status NCT01787123 Phase 2, Phase 3
32 The Use of Nesiritide in Thoracic Aneurysm Repair to Prevent Acute Renal Failure Unknown status NCT00110201 Phase 3
33 Feasibility Study of the LVIS™ (Low-profile Visualized Intraluminal Support)Device Completed NCT01541254 Phase 2, Phase 3
34 Complete Occlusion of Coilable Aneurysms Completed NCT00777907 Phase 3
35 Pivotal Study of the LVIS (Low Profile Visualized Intraluminal Support) Completed NCT01793792 Phase 3
36 Esmolol Infusion in Patients Undergoing Craniotomy Completed NCT02455440 Phase 3
37 Hypothermia During Intracranial Aneurysm Surgery Trial Completed NCT00029133 Phase 3
38 Simvastatin in Aneurysmal Subarachnoid Haemorrhage (STASH) a Multicentre Randomised Controlled Clinical Trial Completed NCT00731627 Phase 3
39 A Randomized Trial of Unruptured Brain AVMs Completed NCT00389181 Phase 3
40 EARLYdrain - Outcome After Early Lumbar CSF-drainage in Aneurysmal SAH Completed NCT01258257 Phase 3
41 Patent Foramen Ovale Closure or Anticoagulants Versus Antiplatelet Therapy to Prevent Stroke Recurrence Completed NCT00562289 Phase 3
42 Clinical Efficacy of In-situ Thrombolysis in Case of Intraventricular Haemorraghia by Aneurysm Rupture Completed NCT00823485 Phase 2, Phase 3
43 High-dose Simvastatin for Aneurysmal Subarachnoid Haemorrhage Completed NCT01077206 Phase 2, Phase 3
44 To Determine the Feasibility of a Clinical Trial Comparing Anticoagulants Versus Antiplatelets in the Acute Treatment of Patients With Cervical Artery Dissection Completed NCT00238667 Phase 3
45 Framing Eighteen Coils in Cerebral Aneurysms Trial Recruiting NCT01655784 Phase 3
46 Ticagrelor vs Clopidogrel for Platelet Inhibition in Stenting for Cerebral Aneurysm Recruiting NCT02675205 Phase 3
47 Esmolol Versus Dexmedetomidine During Intracranial Procedures Recruiting NCT02563288 Phase 3
48 Hypovitaminosis D in Neurocritical Patients Recruiting NCT02881957 Phase 2, Phase 3
49 Ketamine Infusion in Neurologic Deficit Recruiting NCT02636218 Phase 2, Phase 3
50 Ultra-early Tranexamic Acid After Subarachnoid Hemorrhage. Recruiting NCT02684812 Phase 2, Phase 3

Search NIH Clinical Center for Cerebral Aneurysms

Genetic Tests for Cerebral Aneurysms

Genetic tests related to Cerebral Aneurysms:

id Genetic test Affiliating Genes
1 Cerebral Aneurysm 29

Anatomical Context for Cerebral Aneurysms

MalaCards organs/tissues related to Cerebral Aneurysms:

39
Brain, Eye, Endothelial, Liver, Testes, Monocytes, Kidney

Publications for Cerebral Aneurysms

Articles related to Cerebral Aneurysms:

(show top 50) (show all 678)
id Title Authors Year
1
Successful Treatment With Electroconvulsive Therapy of a Patient With Bipolar Disorder and a 7-mm Cerebral Aneurysm. ( 28072662 )
2017
2
Preemptive Medicine for Cerebral Aneurysms. ( 27053328 )
2016
3
Effects of Imaging Parameters on the Quality of Contrast-Enhanced MR Angiography of Cerebral Aneurysms Treated Using Stent-Assisted Coiling: A Phantom Study. ( 27599584 )
2016
4
White-collar sign as a predictor of outcome after endovascular treatment for cerebral aneurysms. ( 27177179 )
2016
5
Bypass Surgeries in the Treatment of Cerebral Aneurysms. ( 27637629 )
2016
6
Sexual Activity as a Risk Factor for the Spontaneous Rupture of Cerebral Aneurysms. ( 27043460 )
2016
7
Prevalence and Characteristics of Unruptured Cerebral Aneurysms in Ischemic Stroke Patients. ( 27488981 )
2016
8
Flow Diversion for Cerebral Aneurysms: A Promising Therapy Needs Full Evaluation. ( 27083132 )
2016
9
Experimental Induction of Cerebral Aneurysms by Developmental Low Copper Diet. ( 27030743 )
2016
10
Endovascular treatment of cerebral aneurysms using the Woven EndoBridge technique in a single center: preliminary results. ( 27081907 )
2016
11
Stent-assisted coiling in ruptured cerebral aneurysms: multi-center experience in acute phase. ( 27631680 )
2016
12
Patient-specific hemodynamics and stress-strain state of cerebral aneurysms. ( 27406681 )
2016
13
Clinical and Angiographic Outcomes of Endovascular Treatment for Ruptured Posterior Circulation Cerebral Aneurysms. ( 27400096 )
2016
14
Thrombus remnant despite intra-arterial thrombolysis for thrombus formation during endovascular treatment of ruptured cerebral aneurysms: Does it harm? ( 27066814 )
2016
15
Molecular Imaging in Neurovascular Diseases: The Use of Ferumoxytol to Assess Cerebral Aneurysms and Arteriovenous Malformations. ( 27049242 )
2016
16
Commentary: Determining the Presence of Thin-Walled Regions at High-Pressure Areas in Unruptured Cerebral Aneurysms by Using Computational Fluid Dynamics. ( 27438407 )
2016
17
Geographic Differences in Endovascular Treatment and Retreatment of Cerebral Aneurysms. ( 27390314 )
2016
18
Extracranial to intracranial bypass for the treatment of cerebral aneurysms in the pediatric population. ( 27430415 )
2016
19
Is there A Genetic Correlation between Multiple Sclerosis and Cerebral Aneurysms? ( 27090970 )
2016
20
Determining the Presence of Thin-Walled Regions at High-Pressure Areas in Unruptured Cerebral Aneurysms by Using Computational Fluid Dynamics. ( 27028475 )
2016
21
Regarding "Computer-Assisted Detection of Cerebral Aneurysms in MR Angiography in a Routine Image-Reading Environment: Effects on Diagnosis by Radiologists". ( 27561835 )
2016
22
Risk of rupture of unruptured cerebral aneurysms in elderly patients. ( 27164645 )
2016
23
Initial and mid-term results from 108 consecutive patients with cerebral aneurysms treated with the WEB device. ( 27075486 )
2016
24
Pipeline Embolization Device for Recurrent Cerebral Aneurysms after Microsurgical Clipping. ( 27350300 )
2016
25
Safety and efficacy of flow re-direction endoluminal device (FRED) in the treatment of cerebral aneurysms: a single center experience. ( 27357157 )
2016
26
Surgical Treatment of Complex Cerebral Aneurysms Using Interposition Short Vein Graft. ( 27637630 )
2016
27
Letter to the Editor: Endoscopic endonasal approach for clip ligation of cerebral aneurysms. ( 27315023 )
2016
28
Diagnostic limitations in the treatment of cerebral aneurysms. ( 27075386 )
2016
29
Hyperhomocysteinemia induced by excessive methionine intake promotes rupture of cerebral aneurysms in ovariectomized rats. ( 27349749 )
2016
30
Clinical outcome after surgical clipping or endovascular coiling for cerebral aneurysms: a pragmatic meta-analysis of randomized and non-randomized trials with short- and long-term follow-up. ( 27053705 )
2016
31
A computational model based on fibrin accumulation for the prediction of stasis thrombosis following flow-diverting treatment in cerebral aneurysms. ( 27106753 )
2016
32
Large Residual Volume, Not Low Packing Density, Is the Most Influential Risk Factor for Recanalization after Coil Embolization of Cerebral Aneurysms. ( 27153192 )
2016
33
The role of estrogen on the pathology of cerebral aneurysms. ( 27177293 )
2016
34
Wall shear stress at the initiation site of cerebral aneurysms. ( 27440126 )
2016
35
Personalized Medicine in Cerebrovascular Neurosurgery: Precision Neurosurgical Management of Cerebral Aneurysms and Subarachnoid Hemorrhage. ( 27446925 )
2016
36
Cerebral Aneurysms: Accuracy of 320-Detector Row Nonsubtracted and Subtracted Volumetric CT Angiography for Diagnosis. ( 27643778 )
2016
37
Infective Endocarditis due to Abiotrophia defectiva and Granulicatella sp. complicated by Infectious Intracranial Cerebral Aneurysms: A Report of 3 Cases and Review of the Literature. ( 27046228 )
2016
38
Biology of Saccular Cerebral Aneurysms: A Review of Current Understanding and Future Directions. ( 27504449 )
2016
39
Aneurysm outflow angle at MRA as discriminant for accurate diagnosis and differentiation between small sidewall cerebral aneurysms and infundibula. ( 27260972 )
2016
40
Comparison of clipping and coiling in elderly patients with unruptured cerebral aneurysms. ( 27203150 )
2016
41
Invasive intracranial arterial pressure monitoring during endovascular cerebral aneurysms embolization for cerebral perfusion evaluation. ( 25366620 )
2015
42
Angiographic appearance of a cerebral aneurysm rupture. ( 26574537 )
2015
43
The efficacy of pre-warming on reducing intraprocedural hypothermia in endovascular coiling of cerebral aneurysms. ( 25670919 )
2015
44
Ophthalmic systems completely supplied from dural arteries indicate the utility of endovascular treatment of cerebral aneurysms. ( 26472634 )
2015
45
Risk of rupture of unruptured cerebral aneurysms in elderly patients. ( 26511450 )
2015
46
Evaluating Post-Interventional Occlusion Grades of Cerebral Aneurysms with Transcranial Contrast-Enhanced Ultrasound (CEUS) Using a Matrix Probe. ( 25629594 )
2015
47
Stability of Cerebral Aneurysms After Stent-Assisted Coil Embolization: A Propensity Score-Matched Analysis. ( 25839376 )
2015
48
Intracardiac Myxoma, Cerebral Aneurysms and Elevated Interleukin-6. ( 26351445 )
2015
49
Comparison of the association of sac growth and coil compaction with recurrence in coil embolized cerebral aneurysms. ( 25894532 )
2015
50
The Use of the Pipeline Embolization Device in the Management of Recurrent Previously Coiled Cerebral Aneurysms. ( 26186670 )
2015

Variations for Cerebral Aneurysms

ClinVar genetic disease variations for Cerebral Aneurysms:

6
id Gene Variation Type Significance SNP ID Assembly Location
1 PKD1 NM_000296.3(PKD1): c.2079dupG (p.Pro694Alafs) duplication Pathogenic rs1057518923 GRCh37 Chromosome 16, 2165397: 2165397

Expression for Cerebral Aneurysms

Search GEO for disease gene expression data for Cerebral Aneurysms.

Pathways for Cerebral Aneurysms

Pathways related to Cerebral Aneurysms according to GeneCards Suite gene sharing:

id Super pathways Score Top Affiliating Genes
1
Show member pathways
12.2 CTSB ELANE ELN
2 11.3 ELANE MPO
3 11.12 CCL2 ELN
4 10.94 ELANE MPO
5 10.75 ELANE ELN
6 10.37 CST3 CTSB
7 9.83 CCL2 MPO

GO Terms for Cerebral Aneurysms

Cellular components related to Cerebral Aneurysms according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 perinuclear region of cytoplasm GO:0048471 9.54 CCL2 CST3 CTSB
2 extracellular space GO:0005615 9.35 CCL2 CST3 CTSB ELANE MPO
3 lysosome GO:0005764 9.33 CST3 CTSB MPO
4 azurophil granule lumen GO:0035578 9.32 ELANE MPO
5 secretory granule GO:0030141 9.26 ELANE MPO
6 extracellular region GO:0005576 9.1 CCL2 CST3 CTSB ELANE ELN MPO

Biological processes related to Cerebral Aneurysms according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 response to lipopolysaccharide GO:0032496 9.5 CCL2 ELANE MPO
2 animal organ morphogenesis GO:0009887 9.48 CCL2 ELN
3 cellular calcium ion homeostasis GO:0006874 9.46 CCL2 ELANE
4 extracellular matrix disassembly GO:0022617 9.43 ELANE ELN
5 response to mechanical stimulus GO:0009612 9.4 CCL2 MPO
6 defense response to fungus GO:0050832 9.37 ELANE MPO
7 negative regulation of growth of symbiont in host GO:0044130 9.26 ELANE MPO
8 neutrophil degranulation GO:0043312 9.26 CST3 CTSB ELANE MPO
9 leukocyte migration involved in inflammatory response GO:0002523 9.16 CCL2 ELANE
10 response to yeast GO:0001878 8.62 ELANE MPO

Molecular functions related to Cerebral Aneurysms according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 protease binding GO:0002020 8.96 CST3 ELANE
2 heparin binding GO:0008201 8.8 CCL2 ELANE MPO

Sources for Cerebral Aneurysms

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....